2020
DOI: 10.21203/rs.2.20571/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Impact of quadrivalent influenza vaccines in Brazil: a cost-effectiveness analysis using an influenza transmission model

Abstract: Background Influenza epidemics significantly weight on the Brazilian healthcare system and its society. Public health authorities have progressively expanded recommendations for vaccination against influenza, particularly to the pediatric population. However, the potential mismatch between the trivalent influenza vaccine (TIV) strains and those circulating during the season remains an issue. Quadrivalent vaccines improves vaccines effectiveness by preventing any potential mismatch on influenza B lineages. Meth… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 14 publications
0
1
0
Order By: Relevance
“…Journal Pre-proof Braziliense, 2021). Estimates by the World Health Organization show that every year at least 650,000 people die from the direct and indirect effects of the influenza virus in the world (Crépey et al, 2020). In fact, a Brazilian study comparing lethality rates between the COVID-19 pandemic and the influenza epidemic in 2009, showed higher rates for influenza (4%) especially in children and adults with comorbidities (Cândido et al, 2020).…”
Section: J O U R N a L P R E -P R O O Fmentioning
confidence: 99%
“…Journal Pre-proof Braziliense, 2021). Estimates by the World Health Organization show that every year at least 650,000 people die from the direct and indirect effects of the influenza virus in the world (Crépey et al, 2020). In fact, a Brazilian study comparing lethality rates between the COVID-19 pandemic and the influenza epidemic in 2009, showed higher rates for influenza (4%) especially in children and adults with comorbidities (Cândido et al, 2020).…”
Section: J O U R N a L P R E -P R O O Fmentioning
confidence: 99%